
PMC:7160442 / 4446-7981
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
50 | 911-919 | Species | denotes | patients | Tax:9606 |
51 | 58-66 | Disease | denotes | COVID-19 | MESH:C000657245 |
52 | 749-754 | Disease | denotes | fever | MESH:D005334 |
53 | 756-767 | Disease | denotes | sore throat | MESH:D010608 |
54 | 772-777 | Disease | denotes | cough | MESH:D003371 |
55 | 788-798 | Disease | denotes | pneumonias | MESH:D011014 |
56 | 950-964 | Disease | denotes | critically ill | MESH:D016638 |
57 | 1002-1010 | Disease | denotes | COVID-19 | MESH:C000657245 |
71 | 1392-1396 | Gene | denotes | ship | Gene:3635 |
72 | 1605-1611 | Species | denotes | people | Tax:9606 |
73 | 1682-1685 | Species | denotes | men | Tax:9606 |
74 | 1690-1696 | Species | denotes | people | Tax:9606 |
75 | 1772-1780 | Species | denotes | Children | Tax:9606 |
76 | 1812-1822 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
77 | 1850-1858 | Species | denotes | children | Tax:9606 |
78 | 1145-1155 | Disease | denotes | infections | MESH:D007239 |
79 | 1439-1449 | Disease | denotes | infections | MESH:D007239 |
80 | 1702-1714 | Disease | denotes | hypertension | MESH:D006973 |
81 | 1716-1724 | Disease | denotes | diabetes | MESH:D003920 |
82 | 1737-1755 | Disease | denotes | pulmonary diseases | MESH:D008171 |
83 | 1798-1806 | Disease | denotes | infected | MESH:D007239 |
87 | 2606-2616 | Chemical | denotes | remdesivir | MESH:C000606551 |
88 | 2618-2636 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
89 | 2658-2667 | Chemical | denotes | lopinavir | MESH:D061466 |
92 | 2972-2976 | Species | denotes | H1N1 | Tax:114727 |
93 | 2890-2898 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T4 | 146-153 | Body_part | denotes | genomes | http://purl.org/sig/ont/fma/fma84116 |
T5 | 761-767 | Body_part | denotes | throat | http://purl.org/sig/ont/fma/fma228738 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T2 | 761-767 | Body_part | denotes | throat | http://purl.obolibrary.org/obo/UBERON_0000341 |
T3 | 2101-2106 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T20 | 58-66 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T21 | 756-767 | Disease | denotes | sore throat | http://purl.obolibrary.org/obo/MONDO_0002258 |
T22 | 788-798 | Disease | denotes | pneumonias | http://purl.obolibrary.org/obo/MONDO_0005249 |
T23 | 1002-1010 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T24 | 1145-1155 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T25 | 1439-1449 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T26 | 1702-1714 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T27 | 1716-1724 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T28 | 1737-1755 | Disease | denotes | pulmonary diseases | http://purl.obolibrary.org/obo/MONDO_0005275 |
T29 | 1812-1820 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T30 | 2005-2019 | Disease | denotes | infectiousness | http://purl.obolibrary.org/obo/MONDO_0005550 |
T31 | 2890-2898 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T32 | 2960-2977 | Disease | denotes | influenza A(H1N1) | http://purl.obolibrary.org/obo/MONDO_0005460 |
T33 | 2960-2969 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T34 | 3412-3421 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22 | 44-49 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T23 | 214-215 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T24 | 252-257 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T25 | 372-373 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T26 | 547-554 | http://purl.obolibrary.org/obo/CLO_0053001 | denotes | 1 to 14 |
T27 | 712-713 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T28 | 1027-1029 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T29 | 1174-1179 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T30 | 1351-1352 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T31 | 1383-1384 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T32 | 1560-1565 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T33 | 1923-1928 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focus |
T34 | 1986-1991 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T35 | 2048-2053 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T36 | 2418-2419 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T37 | 2475-2487 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
T38 | 2641-2642 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T39 | 2726-2727 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T40 | 2824-2826 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T41 | 2835-2836 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T42 | 2970-2971 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T43 | 3090-3103 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organisations |
T44 | 3149-3150 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T45 | 3240-3244 | http://purl.obolibrary.org/obo/CLO_0008416 | denotes | peer |
T46 | 3240-3244 | http://purl.obolibrary.org/obo/CLO_0050081 | denotes | peer |
T47 | 3436-3439 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T48 | 3448-3461 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organisations |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 2431-2440 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T2 | 2451-2456 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T3 | 2606-2616 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T4 | 2618-2636 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T5 | 2658-2681 | Chemical | denotes | lopinavir and ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
T6 | 2658-2667 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T7 | 2672-2681 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T8 | 2698-2708 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
T9 | 2709-2713 | Chemical | denotes | beta | http://purl.obolibrary.org/obo/CHEBI_10545 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T29 | 0-39 | Sentence | denotes | Knowledge gains and remaining questions |
T30 | 40-262 | Sentence | denotes | The virus causing COVID-19 was identified and announced on 7 January and by 10 January, sequences of five genomes had been shared, providing scientists around the world with a basis for development of diagnostic tests [8]. |
T31 | 263-371 | Sentence | denotes | There was fast growing knowledge about several important parameters for understanding the spread of disease. |
T32 | 372-1031 | Sentence | denotes | A number of studies in various settings determined the basic reproductive number R0 to be within the range of 2–3 [9,10]; the incubation period was determined as ranging from 1 to 14 days with an average of 5–6 days; transmission through droplets was established as the main mode of transmission; the clinical picture that emerged included a wide range from mild symptoms with fever, sore throat and cough to severe pneumonias with characteristic features on computed tomography scans; in Hubei, China, up to 13.8% of laboratory-confirmed patients had severe disease, 6.1% were critically ill and the case fatality rate among all COVID-19 cases was 2.3% [11]. |
T33 | 1032-1273 | Sentence | denotes | Further questions on topics such as the possibility of asymptomatic transmission, the proportion of asymptomatic infections, stability of the virus in the environment and main risk groups [12] were partly answered as the pandemic progressed. |
T34 | 1274-1499 | Sentence | denotes | Evidence of asymptomatic transmission was documented in several settings and a study based on an outbreak on a cruise ship determined the proportion of asymptomatic infections as 17.9% (95% credible interval: 15.5–20.2) [13]. |
T35 | 1500-1593 | Sentence | denotes | Laboratory experiments provided data on the survival of the virus on different surfaces [14]. |
T36 | 1594-1771 | Sentence | denotes | Aside from people older than 70 years, severe and fatal cases were seen particularly in men and people with hypertension, diabetes, underlying pulmonary diseases and in smokers. |
T37 | 1772-1918 | Sentence | denotes | Children were shown to be infected with SARS-CoV-2 [15], however, the role of children in disease transmission still needs to be fully elucidated. |
T38 | 1919-2020 | Sentence | denotes | The focus of ongoing research includes determining the duration of virus shedding and infectiousness. |
T39 | 2021-2154 | Sentence | denotes | Development of serological tests with good sensitivity and specificity for wide-scale use is necessary to assess population immunity. |
T40 | 2155-2333 | Sentence | denotes | Serological studies have been started in several European countries to define population immunity and studies on the duration of immunity will need to be conducted in the future. |
T41 | 2334-2457 | Sentence | denotes | Clinical trials are being conducted worldwide to investigate treatment options with a variety of antiviral and other drugs. |
T42 | 2458-2725 | Sentence | denotes | The World Health Organization (WHO) and European Union-funded projects are coordinating multi-centre adaptive trials to assess the effectiveness of remdesivir, hydroxychloroquine and a combination of lopinavir and ritonavir with or without interferon-beta-1a [16,17]. |
T43 | 2726-2834 | Sentence | denotes | A number of vaccine trials are ongoing worldwide with earliest results expected within the coming 18 months. |
T44 | 2835-2992 | Sentence | denotes | A number of questions and challenges that arose in the COVID-19 pandemic appear similar to those experienced during the 2009 influenza A(H1N1)pdm09 pandemic. |
T45 | 2993-3359 | Sentence | denotes | However, information sharing by scientists was faster in 2020, also facilitated by international organisations, widespread social media use and policies of a number of scientific journals, including Eurosurveillance, that enabled fast-tracking of peer-reviewed articles, publishing of articles already deposited in pre-print servers, and making articles open access. |
T46 | 3360-3535 | Sentence | denotes | In particular, the global initiative on sharing all influenza data (GISAID) has allowed organisations like nextstrain.org to collectively perform analysis in almost real time. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T2 | 749-754 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
T3 | 756-767 | Phenotype | denotes | sore throat | http://purl.obolibrary.org/obo/HP_0033050 |
T4 | 772-777 | Phenotype | denotes | cough | http://purl.obolibrary.org/obo/HP_0012735 |
T5 | 788-798 | Phenotype | denotes | pneumonias | http://purl.obolibrary.org/obo/HP_0002090 |
T6 | 1702-1714 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32290905-31992387-29338432 | 259-260 | 31992387 | denotes | 8 |
32290905-32052846-29338433 | 487-488 | 32052846 | denotes | 9 |
32290905-32097725-29338434 | 489-491 | 32097725 | denotes | 10 |
32290905-32183930-29338435 | 1495-1497 | 32183930 | denotes | 13 |
32290905-32182409-29338436 | 1589-1591 | 32182409 | denotes | 14 |
32290905-32187458-29338437 | 1824-1826 | 32187458 | denotes | 15 |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32290905-31992387-29338432 | 259-260 | 31992387 | denotes | 8 |
32290905-32052846-29338433 | 487-488 | 32052846 | denotes | 9 |
32290905-32097725-29338434 | 489-491 | 32097725 | denotes | 10 |
32290905-32183930-29338435 | 1495-1497 | 32183930 | denotes | 13 |
32290905-32182409-29338436 | 1589-1591 | 32182409 | denotes | 14 |
32290905-32187458-29338437 | 1824-1826 | 32187458 | denotes | 15 |